Michael Finegan
Director/Board Member at ORTHOFIX MEDICAL INC.
Net worth: - $ as of 30/05/2024
Profile
Michael M.
Finegan is currently the Chief Executive Officer at Acera Surgical, Inc. and an Independent Director at Orthofix Medical, Inc. He previously worked as the Vice President-Corporate Sales at Boston Scientific Corp.
and as the Chief Strategy Officer at Orthofix Medical, Inc. from 2013 to 2020.
Finegan received his undergraduate degree from Wake Forest University in 1985.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ORTHOFIX MEDICAL, INC.
-.--% | 21/04/2024 | 0 ( -.--% ) | - $ | 30/05/2024 |
Michael Finegan active positions
Companies | Position | Start |
---|---|---|
ORTHOFIX MEDICAL INC. | Director/Board Member | 13/12/2023 |
Acera Surgical, Inc.
Acera Surgical, Inc. Miscellaneous ManufacturingProducer Manufacturing Acera Surgical, Inc. engages in developing a portfolio of fully synthetic surgical materials that act as resorbable scaffolds for soft tissue repair and regeneration. Its products are designed to improve surgical efficiency, reduce surgical complications and cost, and facilitating superior clinical outcomes. The company was founded by Agnes Rey-Giraud and Matthew MacEwan and is headquartered in St Louis, MO. | Chief Executive Officer | 10/05/2022 |
Former positions of Michael Finegan
Companies | Position | End |
---|---|---|
ORTHOFIX MEDICAL INC. | Corporate Officer/Principal | 03/07/2020 |
BOSTON SCIENTIFIC CORPORATION | Sales & Marketing | - |
Training of Michael Finegan
Wake Forest University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ORTHOFIX MEDICAL INC. | Health Technology |
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Private companies | 1 |
---|---|
Acera Surgical, Inc.
Acera Surgical, Inc. Miscellaneous ManufacturingProducer Manufacturing Acera Surgical, Inc. engages in developing a portfolio of fully synthetic surgical materials that act as resorbable scaffolds for soft tissue repair and regeneration. Its products are designed to improve surgical efficiency, reduce surgical complications and cost, and facilitating superior clinical outcomes. The company was founded by Agnes Rey-Giraud and Matthew MacEwan and is headquartered in St Louis, MO. | Producer Manufacturing |
- Stock Market
- Insiders
- Michael Finegan